US 12054556
Anti-PD-L1 antibody and use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 12054556 (Anti-PD-L1 antibody and use thereof) held by Oricell Therapeutics Co., Ltd. expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oricell Therapeutics Co., Ltd.
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00